HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PD 134308

selective cholecystokinin type B receptor antagonist; inhibits growth of LoVo, a human colon cancer cell line; structure given in first source
Also Known As:
4-((2-((3-(1H-indol-3-yl)-2-methyl-1-oxo-2-(((tricyclo(3.3.1.1)-dec-2-yloxy)carbonyl)amino)propyl)amino)-1-phenethyl)amino)-4-oxobutanoate N-methyl-D-glucamine; CI 988; CI-988; PD-134308; PD134308
Networked: 27 relevant articles (2 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kim, Junesun: 2 articles (03/2015 - 10/2009)
2. Kim, Youngkyung: 2 articles (03/2015 - 10/2009)
3. Yoon, Young Wook: 2 articles (03/2015 - 10/2009)
4. Chen, Ken: 1 article (01/2020)
5. Chen, Zhi: 1 article (01/2020)
6. Duan, Xudong: 1 article (01/2020)
7. He, Hongye: 1 article (01/2020)
8. Huang, Yu: 1 article (01/2020)
9. Liu, Chao: 1 article (01/2020)
10. Ren, Hongmei: 1 article (01/2020)

Related Diseases

1. Anxiety Disorders (Anxiety Disorder)
2. Substance-Related Disorders (Drug Abuse)
3. Pain (Aches)
4. Neuralgia (Stump Neuralgia)
5. Panic Disorder (Panic Attack)

Related Drugs and Biologics

1. Fluoxetine (Prozac)
2. Opioid Analgesics (Opioids)
3. RB 120
4. Cholecystokinin B Receptor
5. Morphine (MS Contin)
6. Cholecystokinin (Pancreozymin)
7. Gastrins
8. Ligands
9. Peptoids
10. Galanin

Related Therapies and Procedures

1. Analgesia
2. Axotomy